Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
FDA approval
Pharma
Vanda, Agios score holiday season FDA approvals
The FDA delivered a pair of holiday season nods, signing off on Agios’ Aqvesme for thalassemia and Vanda's motion sickness pill Nereus.
Kevin Dunleavy
Jan 2, 2026 11:33am
FDA signs off on Omeros' stem cell transplant drug Yartemlea
Dec 26, 2025 12:46pm
Novo snags FDA nod for oral obesity med with Wegovy in a pill
Dec 22, 2025 6:59pm
Cytokinetics scores its first FDA nod with Myqorzo approval
Dec 22, 2025 12:05pm
GSK scoops up yet another FDA approval, this time in asthma
Dec 17, 2025 8:30am
FDA approves AZ/Daiichi's Enhertu in 1st-line breast cancer
Dec 15, 2025 4:15pm
